Literature DB >> 26974247

Predictors of trajectories of epilepsy-specific quality of life among children newly diagnosed with epilepsy.

Rachelle R Ramsey1, Kristin Loiselle1, Joseph R Rausch1, Jordan Harrison2, Avani C Modi3.   

Abstract

OBJECTIVE: The objective of this study was to identify two-year trajectories of epilepsy-specific health-related quality of life (HRQOL) among children newly diagnosed with epilepsy and to evaluate the predictive value of a comprehensive set of medical, psychosocial, and family factors.
METHODS: Ninety-four children with epilepsy (8.14 ± 2.37 years of age and 63% male) and their caregivers participated in this study. Caregivers completed the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE) and measures of psychological and family functioning at one month postdiagnosis. The QOLCE was also given at eight additional time points during the subsequent two years as a part of a large observational study in children with epilepsy. Adherence data were collected via MEMS TrackCaps, and medical information was collected through chart review.
RESULTS: Unique trajectories were identified for the overall QOLCE scale, as well as the subscales. Most trajectory models for the QOLCE subscales contained at least one at-risk trajectory for children, indicating that there is a subgroup of children experiencing poor long-term HRQOL. Health-related quality-of-life trajectories remained predominantly stable during the two-year period following treatment initiation. The number of AEDs, internalizing problems, and externalizing problems emerged as the most consistent predictors across the HRQOL domains. SIGNIFICANCE: Medical and psychosocial interventions, such as cognitive-behavioral strategies, should target modifiable factors (e.g., internalizing symptoms, externalizing symptoms, number of AEDs trialed) shortly after diagnosis to improve HRQOL for children with epilepsy over the course of their disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Epilepsy; Quality of life; Trajectories

Mesh:

Substances:

Year:  2016        PMID: 26974247      PMCID: PMC4828263          DOI: 10.1016/j.yebeh.2016.02.002

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  38 in total

1.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

2.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

3.  Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan.

Authors:  R H Alwash; M J Hussein; F F Matloub
Journal:  Seizure       Date:  2000-09       Impact factor: 3.184

Review 4.  Depression in children and adolescents with epilepsy.

Authors:  Sigita Plioplys
Journal:  Epilepsy Behav       Date:  2003-10       Impact factor: 2.937

5.  Development of scales to measure psychosocial care needs of children with seizures and their parents. 1.

Authors:  J Austin; D Dunn; G Huster; D Rose
Journal:  J Neurosci Nurs       Date:  1998-06       Impact factor: 1.230

6.  ADHD and epilepsy in childhood.

Authors:  David W Dunn; Joan K Austin; Jaroslaw Harezlak; Walter T Ambrosius
Journal:  Dev Med Child Neurol       Date:  2003-01       Impact factor: 5.449

7.  Patient adherence and medical treatment outcomes: a meta-analysis.

Authors:  M Robin DiMatteo; Patrick J Giordani; Heidi S Lepper; Thomas W Croghan
Journal:  Med Care       Date:  2002-09       Impact factor: 2.983

8.  The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity.

Authors:  James W Varni; Tasha M Burwinkle; Michael Seid; Douglas Skarr
Journal:  Ambul Pediatr       Date:  2003 Nov-Dec

9.  Validation of the quality of life in childhood epilepsy questionnaire in American epilepsy patients.

Authors:  Mark Sabaz; John A Lawson; David R Cairns; Michael S Duchowny; Trevor J Resnick; Patricia M Dean; Ann M E Bye
Journal:  Epilepsy Behav       Date:  2003-12       Impact factor: 2.937

10.  Anxiety in children with epilepsy.

Authors:  Jane Williams; Chris Steel; Gregory B Sharp; Emily DelosReyes; Tonya Phillips; Stephen Bates; Bernadette Lange; May L Griebel
Journal:  Epilepsy Behav       Date:  2003-12       Impact factor: 2.937

View more
  6 in total

1.  Adherence barriers in pediatric epilepsy: From toddlers to young adults.

Authors:  Ana M Gutierrez-Colina; Aimee W Smith; Constance A Mara; Avani C Modi
Journal:  Epilepsy Behav       Date:  2018-02-09       Impact factor: 2.937

2.  Uncovering Key Elements of an Executive Functioning Intervention in Adolescents: Epilepsy Journey.

Authors:  Ana M Gutierrez-Colina; Lisa Clifford; Shari L Wade; Avani C Modi
Journal:  Clin Pract Pediatr Psychol       Date:  2021-09-02

Review 3.  Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy.

Authors:  Bruce P Hermann; Aaron F Struck; Robyn M Busch; Anny Reyes; Erik Kaestner; Carrie R McDonald
Journal:  Nat Rev Neurol       Date:  2021-09-22       Impact factor: 44.711

Review 4.  Psychological treatments for people with epilepsy.

Authors:  Rosa Michaelis; Venus Tang; Sarah J Nevitt; Janelle L Wagner; Avani C Modi; William Curt LaFrance; Laura H Goldstein; Milena Gandy; Rebecca Bresnahan; Kette Valente; Kirsten A Donald; Markus Reuber
Journal:  Cochrane Database Syst Rev       Date:  2020-09-07

Review 5.  Psychological treatments for people with epilepsy.

Authors:  Rosa Michaelis; Venus Tang; Janelle L Wagner; Avani C Modi; William Curt LaFrance; Laura H Goldstein; Tobias Lundgren; Markus Reuber
Journal:  Cochrane Database Syst Rev       Date:  2017-10-27

6.  Epilepsy in adulthood: Prevalence, incidence, and associated antiepileptic drug use in autistic adults in a state Medicaid system.

Authors:  Lauren Bishop; Kiley J McLean; Eric Rubenstein
Journal:  Autism       Date:  2020-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.